Winton Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,949
Closed -$553K 1249
2018
Q4
$553K Sell
3,949
-659
-14% -$100K 0.01% 459
2018
Q3
$787K Buy
4,608
+968
+27% +$163K 0.02% 456
2018
Q2
$631K Sell
3,640
-4,688
-56% -$705K 0.02% 559
2018
Q1
$961K Buy
+8,328
New +$886K 0.03% 516

Other funds holding LOXO

Winton Group's LOXO Position: Q1 2019 in Review

Winton Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 3,949 shares — an estimated $553K sold.

Winton Group first reported a position in LOXO in Q1 2018 and held it in 4 quarters. The position peaked at $961K in Q1 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Winton Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Winton Group sold 3,949 Loxo Oncology, Inc shares in Q1 2019, an estimated $553K.
  • Winton Group first reported a position in Loxo Oncology, Inc in Q1 2018 and held it in 4 quarters.
  • Winton Group's Loxo Oncology, Inc position peaked at $961K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Winton Group's 13F filing for Q1 2019, filed 13 May 2019.